Skip to content

The effect of dezocine on the effective dose of sufentanil to suppress the cardiovascular reaction in patients during anesthesia induction and endotracheal intubation

The effect of dezocine on the effective dose of sufentanil to suppress the cardiovascular reaction in patients during anesthesia induction and endotracheal intubation

Status
Recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000039261
Enrollment
Unknown
Registered
2020-10-22
Start date
2020-10-31
Completion date
Unknown
Last updated
2021-01-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular response to endotracheal intubation

Interventions

Case series:The endotracheal intubation response was suppressed with sufentanil

Sponsors

Taizhou Hospital of Zhejiang Province
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing endotracheal intubation under general anesthesia in our hospital; 2. ASA I - II patients; 3. Patients aged 18-65 years.

Exclusion criteria

Exclusion criteria: 1. The patient has a history of difficult intubation, or in this study, one-time intubation failure; 2. Patients with a history of abuse of opioids or other sedative drugs before operation; 3. Patients with diseases of liver, kidney or blood system; 4. Patients with high risk of reflux aspiration; 5. Patients with BMI > 30 kg / m2 or < 18 kg / m2; 6. Patients with severe cardiopulmonary diseases before operation; 7. Patients with blood pressure less than 90 mmHg and heart rate less than 45 beats / min during induction.

Design outcomes

Primary

MeasureTime frame
Blood pressure;Heart rate;

Countries

China

Contacts

Public ContactNanjin Chen

Department of Anesthesiology, Taizhou Hospital of Zhejiang Province

chennj@enzemed.com+86 13750668783

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026